Converge Bio vs Terray Therapeutics
Which Drug Discovery AI tool is better in 2026?
Converge Bio
Generative AI hub of foundation models across DNA, RNA, protein, and small molecules
Terray Therapeutics
Generative AI and ultra-high-throughput chemistry for small-molecule drug discovery
Side-by-side
Terray Therapeutics is the more established option (raised $180M); pricing is comparable on both sides.
| Metric | Converge Bio | Terray Therapeutics |
|---|---|---|
| Taglinei | Generative AI hub of foundation models across DNA, RNA, protein, and small molecules | Generative AI and ultra-high-throughput chemistry for small-molecule drug discovery |
| Foundedi | 2023 | 2018🏆 |
| HQi | Boston, US | Monrovia, US |
| Employeesi | 11-50 | 51-200🏆 |
| Neuron scorei | 64 | 74🏆 |
| Total fundingi | $30.5M | $180M🏆 |
| Latest roundi | Seed | Series B · Oct 2024 |
| Valuationi | — | — |
| Cheapest paid plani | Pricing not disclosed | Pricing not disclosed |
| Free plani | ✓ | ✗ |
| Free triali | ✓ | ✗ |
| Top tier pricei | Pricing not disclosed | Pricing not disclosed |
| Pricing summaryi | Free | Enterprise · Contact sales |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Converge Bio and Terray Therapeutics.
| Capability | Converge Bio | Terray Therapeutics |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✓ | ✗ |
| Free trial | ✓ | ✗ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Converge Bio
- Offers a free plan
- Offers a free trial
- Newer company (2023)
🔵 Strengths of Terray Therapeutics
- Has raised more capital ($180M vs $30.5M)
- Higher Neuron score (74 vs 64)
- More mature (2018)
Which should you choose?
Choose Terray Therapeutics if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both Drug Discovery tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Terray Therapeutics if you want the most established option — it has raised $180M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Converge Bio vs Terray Therapeutics — which is better?
It depends on your priority. Converge Bio is the leaner option; Terray Therapeutics has broader feature depth. See the side-by-side table above.
Is Converge Bio cheaper than Terray Therapeutics?
No — Terray Therapeutics's cheapest paid plan is Enterprise · Contact sales, while Converge Bio's is Free.
Do Converge Bio and Terray Therapeutics offer free plans?
Converge Bio: Yes, has a free plan. Terray Therapeutics: Paid only.
Explore more Drug Discovery tools
Contextual paths to related AI startups, deals and rankings.